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Among the more than one hundred formally described human papillomavirus (HPV) types, 18 are referred
to as high-risk HPV types due to their association with anogenital cancer. Despite pathogenic similarities, these
types form three remotely related taxonomic groups. One of these groups is called HPV species 9 and is formed
by HPV-16, the most common and best-studied type, together with HPV-31, -33, -35, -52, -58, and -67. Previous
worldwide comparisons of HPV-16 samples showed about 2% nucleotide diversity between isolates, which were
subsequently termed variants. The distribution of divergent variants has been found to correlate frequently
with the geographic origin and the ethnicity of the infected patients and led to the concept of unique African,
European, Asian, and Native American HPV-16 variants. In the current study, we address the question of
whether geography and ethnicity also correlate with sequence variations found for HPV-31, -35, -52, and -58.
This was done by sequencing the long control region in samples derived from Europe, Asia, and Africa, and
from immigrant populations in North and South America. We observed maximal divergence between any two
variants within each of these four HPV types ranging from 1.8 to 3.6% based on nucleotide exchanges and,
occasionally, on insertions and deletions. Similar to the case with HPV-16, these mutations are not random but
indicate a relationship between the variants in form of phylogenetic trees. An interesting example is presented
by a 16-bp insert in select variants of HPV-35, which appears to have given rise to additional variants by
nucleotide exchanges within the insert. All trees showed distinct phylogenetic topologies, ranging from dich-
otomic branching in the case of HPV-31 to star phylogenies of the other three types. No clear similarities
between these types or between these types and HPV-16 exist. While variant branches in some types were
specific for Europe, Africa, or East Asia, none of the four trees reflected human evolution and spread to the
extent illustrated by HPV-16. One possible explanation is that the rare HPV types that we studied spread and
thereby diversified more slowly than the more abundant HPV-16 and may have established much of today’s
variant diversity already before the worldwide spread of humans 100,000 years ago. Most variants had
prototypic amino acid sequences within the E6 oncoprotein and a segment of the L1 capsid protein. Some had
one, two, or three amino acid substitutions in these regions, which might indicate biological and pathogenic
diversity between the variants of each HPV type.
The phylogeny-based taxonomy of papillomaviruses (PVs)
places these viruses into a separate family which is further
divided into genera and species (11). On lower taxonomic
levels, PVs are classified as types, subtypes, and variants. Basic
and clinical research normally addresses PVs on these lower
three levels of taxonomy. More than one hundred different
human papillomavirus (HPV) types have been formally de-
scribed (1, 9, 11). Eighteen HPV types are of particular inter-
est, as they are frequently associated with anogenital cancer
and therefore classified as high-risk HPV types (23). Para-
digms for the high-risk HPVs are HPV type 16 (HPV-16) and
HPV-18, which are only remotely related to one another.
HPV-16 and -18 form two separate phylogenetic groups, each
* Corresponding author. Mailing address: Department of Molecular
Biology and Biochemistry, University of California, Irvine, CA 92697-
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together with six other HPV types. These groups are now
called HPV species 9 and 7, respectively (11).
An HPV type is defined as a separate taxon when the nu-
cleotide sequence of its L1 gene differs from that of any other
HPV type by at least 10%. The additional term “subtype”
defines a HPV genome whose L1 nucleotide sequence is
greater than 2% and less than 10% different from that of the
closest type (11). Only a very few HPV subtypes have been
described. Our recent analyses of many isolates of two HPV
types (HPV-44 and HPV-68) that have given rise to subtypes
led to the calculation of dichotomic phylogenetic trees, which
indicated an ancient origin of the “subtype” taxa (6).
While subtypes of HPV types are rare, each HPV type com-
prises numerous genomic variants whose numbers are never-
theless relatively small (tens or hundreds of variants) in com-
parison to the quasispecies formed by rapidly evolving RNA
viruses whose diversity is several orders of magnitude higher.
Variants of HPV types differ by less than 2% of their L1
nucleotide sequences but slightly more in the long control
region (LCR), which does not encode genes and is therefore
less restricted in its ability to accumulate and tolerate muta-
tions (15, 34). Genomic variation of HPV-16 and HPV-18 has
been particularly well studied. Variants of these two types form
phylogenetic trees with branches formed by variants with high
prevalence in cohorts in Africa, Europe, or East Asia, with one
of the East Asian phylogenetic branches of variants extending
into populations of Native Americans (16, 24). Thus, these
trees are reflective of the evolution and worldwide migration
patterns of the human host (3) and suggested that certain
variants diverged at approximately the same time when the
major human ethnic groups formed.
Subsequent studies have addressed the genomic variabilities
of HPV-6 and -11 in genital warts (14); HPV-2, -27, and -57 in
common warts (8); HPV-5 in epidermodysplasia verruciformis
(10); and rare HPV types in small numbers of cervical lesions
(29). All of these studies agree that all HPV types (i) have
given rise to a limited and relatively small number of genomic
variants, (ii) show a small fraction of genomic diversity (less
than 2% in the L1 gene and only slightly more in hypervariable
regions like the LCR), and (iii) show geographic specificity, at
least for some variants. However, these studies did not docu-
ment a close linkage between intratype HPV evolution and the
evolution and migration of humans as revealed in the studies of
HPV-16 and -18 (16, 24).
This paper is the third of three recent publications that
address the issue of intratype evolution of HPVs. In the first
report, we studied the diversity of HPV types 44 and 68 and
their subtypes and variants (6). In the second report, we ad-
dressed the diversity of HPV-53, -56, and -66 (26), which form
HPV species 6. This represents the third major group in the
taxonomy of HPVs in addition to the two species formed by the
relatives of HPV-16 and -18. The current study reports on the
diversity of four HPV types, HPV-31, -35, -52, and -58, which
are closely related to HPV-16. We have been able to examine
the intratype diversity of these rare HPVs in collaboration with
colleagues involved in HPV studies throughout the world. The
data we report confirm the notion of a limited genomic diver-
sity for each of these HPV types and geographic clustering of
some HPV variants that suggests slower rates of molecular
evolution than previously proposed for HPV-16 and -18 (16,
24). In contrast to HPV-16 and -18, which diversified only by
nucleotide exchanges, some of these rarer HPV types show
significant amounts of deletions and insertions. This appears to
be a rarely encountered mechanism of HPV evolution. Amino
acid substitutions of HPV oncoproteins and capsid proteins
are rare but do occur and have to be considered in studies of
pathogenicity and vaccine development.
MATERIALS AND METHODS
Sample collection. In order to explore the intratype phylogeny of HPV-31, -35,
-52, and -58, we examined the sequence diversity within the LCRs of isolates
from seven geographically remote cohorts from Sao Paulo, Brazil (BR); Hong
Kong; Monterrey, Mexico; Edinburgh, Scotland (ED); Cape Town, South Africa
(SA); Oslo, Norway; Oklahoma; and Los Angeles, California. We also included
fewer samples from Heidelberg, Germany; Mali; Morocco (MR); Taiwan; The
Philippines; and Thailand. Most of the samples from South Africa were from
patients of African ethnicity (SA samples), while some were from people of
mixed ethnicity (SA* samples). All patients from Hong Kong and Taiwan were
ethnic Chinese. All samples had been collected during past or ongoing diagnostic
and epidemiological research of cervical smears in studies that are unrelated to
the objectives of our project. No patient was sampled solely for the purpose of
our research.
Phylogenetically informative amplicons of the LCR. As in our previous studies
on the genomic diversity of HPV types, we aimed to amplify a segment of the
LCR, which would likely contain a sufficient number (e.g., 20 to 50) of mutations
to generate stable phylogenetic trees. No effort was made to amplify the whole
LCR. For studying HPV-31, a 523-bp segment between the genomic positions
7527 and 137 was amplified with primers 31-8aF (5-AGTAGTTCTGCGGTTT
TTGGTTTC-3) and 31-8aR (5-CCGAGGTCTTTCTGCAGGATTTTT-3).
The genomic sequence was established for 503 bp of the 523-bp fragment. Of the
70 isolates, the known sequences are deposited in GenBank under the access
codes AY453992 to AY454037. In order to exclude possible PCR artifacts, all
samples were amplified twice and both strands were sequenced twice. The same
precaution applied to the treatment of the HPV-35, -52, and -58 samples. For
studying HPV-35, we amplified a 893-bp fragment between genomic positions
7146 and 187 with the primers 35LCR-F (5-TATATTATGTGTTGTGGTGC
CTGTTTG-3) and 35LCRa-R (5-CGTTTTCGGTCACTCCCTGTTTT-3).
The genomic sequence was established for 814 bp of the 893-bp fragment. Of the
45 isolates, known sequences are deposited in GenBank under the access codes
AY454064 to AY454038. Genomic segments of HPV-52 were amplified by PCR
using the primers HPV-52-LF (5-TTGTCTGTTGGGTAATTGTCTGTG-3)
and HPV-52-LR (5-CGTAACCGGTCGTGTAGTGC-3), which generated a
750-bp segment between the genomic positions 7158 and 7907. The genomic
sequence was established for 637 bp of the 750-bp fragment. Genomic segments
of HPV-58 were amplified by PCR with the primers 58-UF (5-TATGAGTAA
GGTGCTGTCCCT-3) and 58-UR (5-CGGTCTGACCGAAACCGGTGC-
3), which generated a 545-bp segment between the genomic positions 7345 and
68. The genomic sequence was established for 461 bp of the 545-bp fragment.
Amplification with E6 and L1 consensus primers. The HPV-52, -58, -31, and
-35 E6 genes were amplified with type-specific primers. For HPV-31, E631-F
(5-AAAAGTAGGGAGTGACCGAAAGTGG-3) and E631-R (5-TCGGGT
AATTGCTCATAACAGTGGA-3) were used, resulting in a 625-bp fragment;
for HPV-35, E635-F (5-CGAAAACGGTTGCCATAAAAG-3) and E635-R
(5-TGCCTCGGGTTCCAAATCTA-3) were used, resulting in a 578-bp frag-
ment; for HPV-52, E652-F (5-ACGCACGGCCATGTTTGAGGAT-3) and
E652-R (5-TAATTGCTTGTGGCTTGTTCTGCTTGTC-3) were used, result-
ing in a 622-bp fragment; and for HPV-58, E658-F (5-AGGCTACTGCAGGA
CTATGTTC-3) and E658-R (5-AGCGTTGGGTTGTTTCCTCTCA-3) were
used, resulting in a 503-bp fragment. The genomic sequences were established
for 447 bp (HPV-52) and 450 bp (HPV-58, -31, and -35). A PCR fragment (450
bp) of the L1 gene was amplified with the consensus primers MY09/MY11 (2, 4),
and the genomic sequences were established for 351 bp (HPV-31 and -35) and
421 bp (HPV-52 and -58) of these 450 bp.
PCR amplification, sequence analysis, and phylogenetic evaluations. PCR
mixtures contained 20 mM Tris, pH 8.0, 100 mM KCl, 200 mM of each de-
oxynucleoside triphosphate, 2 mM MgCl2, 10 mM of each sense and antisense
oligonucleotide primer, and 1 unit of Taq polymerase (Promega, Madison, WI).
Forty amplification cycles were run in the Eppendorf Master Cycler with a 94°C
denaturing step (30 s), a 60°C annealing step (30 s), and a 72°C extension step (60
s). PCR amplicons were separated electrophoretically on 2% agarose gel, puri-
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fied with Exo I and alkaline phosphatase (USB, Cleveland, OH), and applied to
enzymatic extension reactions for DNA sequencing using the ABI PRISM Big-
Dye Cycle sequencing kit (AB Applied Biosystems). Both strands were se-
quenced with the same forward and reverse primers as those used for PCR
amplification of the LCR unless stated differently. The sequencing reactions
were purified by ethanol-sodium acetate precipitation and then run on an ABI
Prism 3100 sequencer. The mutations were analyzed and determined by the
ALIGN program at the GENESTREAM network server (25) (http://www2.igh
.curs.fr/bin/align-guess.cgi). The neighbor-joining and unweighted-pair group
method with arithmetic average (UPGMA) trees were constructed by using
Mega version 2.1. All reference (or prototype) sequences were taken from the
Los Alamos-based HPV sequence database (http://hpv-web.lanl.gov/stdgen/virus
/hpv/compendium/htdocs/). In the case of HPV-35, the prototype sequence is
reported at this site as HPV-35H, which corrected several mistakes published in
a previous report.
Nucleotide sequence accession numbers. The new sequences of HPV-31 are
published with the GenBank accession codes DQ057247 to DQ057270. The new
sequences of HPV-35 are published with the GenBank access codes DQ057271
to DQ057289. The sequences of all 66 isolates of HPV-52 are published with the
GenBank access codes DQ057080 to DQ057145. The sequences of all 101 iso-
lates of HPV-58 are published with the GenBank access codes DQ057146 to
DQ057246. The sequences of all isolates of E6 gene amplification are published
with the following GenBank access codes: for E6-amplified HPV-31, DQ057302
to DQ057308; for E6-amplified HPV-35, DQ057309 to DQ057314; for E6-am-
plified HPV-52, DQ057290 to DQ057295; and for E6-amplified HPV-58,
DQ057296 to DQ057301. The L1 MY09/11 GenBank codes are as follows: for
HPV-52, DQ057315 to DQ057320; for HPV-58, DQ057321 to DQ057326; for
HPV-31, DQ057327 to DQ057333; and for HPV-35, DQ057334 to DQ057339.
RESULTS
Genomic diversity of HPV-31 isolates. The HPV-31 refer-
ence genome was isolated from a cervical dysplasia (20).
HPV-31 is considered a high-risk HPV type and the fourth
most common HPV type in squamous cervical carcinomas and
in asymptomatic patients worldwide (23). The genomic diver-
sity of HPV-31 has been investigated in two regional studies (5,
12). Some of the samples described in this article are identical
to those in the first of these two publications and are thus
identified by the same abbreviations.
We analyzed a 503-bp fragment of the LCR of 69 HPV-31
samples and identified 28 variants (including the reference
genome) with 28 point mutations and a 7-bp deletion relative
to the HPV-31 genome. The deletion occurred in only four
samples, namely, MX80, MX635, MX701, and MX1144. Max-
imal distance between any two variants was 14 mutations (2.8%
of the 503-bp sequence), considering the deletion a single
event. A total of 17 of the 28 variants were found in only a
single sample, and 6 variants were found in two samples. The
HPV-31 reference clone was found in 26 samples.
Gagnon and colleagues (12) could identify 18 variants (in-
cluding the reference genome). The amplicons studied by this
group and by us overlapped but extended in different direc-
tions. Based on the overlap, we observed 23 variants and Gag-
non and colleagues observed 13 variants, and five of these
variants were not observed in our study. Based on these num-
bers, our study detected more than 80% of the more common
and widely distributed HPV-31 variants.
Figure 1 shows a phylogenetic tree of HPV-31 isolates based
on the UPGMA algorithm (large figure) and a second tree
based on the neighbor-joining method, where each variant is
represented by a single isolate (small insert). These trees were
calculated weighting each mutation equally except in the case
of the deletion. The deletion was given the weight of two
mutations, since we assumed that such a rare and specific event
likely occurred only a single time. In phylogenetic trees calcu-
lated without introducing this bias, the variants MX800,
MX635, MX701, and MX1144 did not cluster together.
These trees can be characterized as dichotomic, i.e., being
split into two major branches rather than having several
branches of similar distance (star phylogenies), such as the
published trees of HPV-16 variants (16). Surprisingly, there
was no deep branching based on geographic origin or on eth-
nicity of the patient as in HPV-16 and HPV-18 trees. A divi-
sion into two branches of presumed geographic specificity, as
proposed based on the previously studied small data set (5),
was not supported by the addition of many new samples in this
project. For example, all samples from Hong Kong and Taiwan
contained the HPV-31 reference clone, which also predomi-
nated in Norway and Brazil. Two minor branches appear to be
based on geographic location, namely, five of the six samples
from South Africa (SA*1073 clustering with SA2157, SA*1415
with SA*1509, and SA1644). In addition, the 7-bp deletion
mentioned above was observed in four variants of Mexican
origin. As such a specific deletion would seem to be a rare
event and unlikely to occur more than once, these four variants
are likely related and may constitute a phylogenetic assembly
originating from Native Americans.
Genomic diversity of HPV-35 isolates. The HPV-35 refer-
ence genome was isolated from an endocervical adenocarci-
noma (21). HPV-35 is considered a high-risk HPV type and,
worldwide, is the eighth most common HPV type in squamous
cervical carcinomas and the seventh most common HPV type
in asymptomatic control patients (23). Previously, only two
genomic variants of HPV-35 were found through worldwide
sampling (29), while a recent pilot study from our lab detected
nine variants in a small number of cohorts (5). Some of the
samples described in this article are identical to those in our
previous publication and are identified by the same abbrevia-
tions. For the genomic sequence of the HPV-35 reference
clone, we used the sequence HPV-35H as corrected and dis-
cussed at http://hpv-web.lanl.gov/stdgen/virus/hpv/compendium
/htdocs/.
We analyzed an 814-bp fragment of the LCR of 47 HPV-35
samples and identified 12 variants with nucleotide exchanges, a
single nucleotide deletion, and a 16-bp insertion relative to the
reference genome. The latter was present in 33 samples.
Within this 16-bp insert, we observed an additional single nu-
cleotide exchange in two variants (10 samples) and 10 nucle-
otide exchanges in one sample (SA2299), suggestive of an
ancient origin of this insertion. To clarify this unique observa-
tion, the raw sequencing data are shown in Fig. 2. Maximal
distance between any two variants was 15 mutations (1.8%),
considering the insertion a single event and counting the ad-
ditional point mutations in SA2299. It is evident from the
phylogenetic tree in Fig. 3 that the HPV-35 reference clone
was found in only four samples (8.5%). In contrast, two vari-
ants with the insertion and specific patterns of points mutations
elsewhere occurred in 16 (34%) and nine samples (19.1%),
respectively, and seem to be the predominating HPV-35 ge-
nomes worldwide.
Figure 3 shows the relationship between all HPV-35 isolates
based on the UPGMA algorithm (large tree) and the neighbor-
joining algorithms, selecting one isolate to represent each vari-
ant (small insert). As it seems very likely that the 16-bp inser-
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tion/deletion occurred a single time, we calculated the
neighbor-joining tree (Fig. 3, small insert) by overweighting the
insertion by a factor of three. When the insertion was entered
as a single event, the variants without or with the insertion did
not form separate branches. This assumption creates a dichot-
omy of the tree which is mathematically artificial but likely
reflects phylogenetic sequential events, considering how un-
likely multiple occurrences of this highly specific mutation may
be. It should be noted that African, European, and Asian
isolates occurred multiple times in samples with and without
this insert, which favors the hypothesis that this insertion/de-
letion event predated the spread of humans.
Genomic diversity of HPV-52 isolates. The HPV-52 refer-
ence genome was isolated from a cervical intraepithelial neo-
plasia (27). HPV-52 is considered a high-risk HPV type.
Worldwide, it is the sixth most common HPV type in cervical
FIG. 1. The intratype diversity of HPV-31. The phylogenetic trees represent the relationship between HPV-31 variants based on a 503-bp
segment of the LCR. The large tree is based on the UPGMA, and the small tree is based on the neighbor-joining algorithm. The UPGMA tree
represents all isolates, while those that were chosen to represent a particular variant in the neighbor-joining tree are indicated by black triangles.
BR, Sao Paulo (Brazil); ED, Edinburgh (Scotland); HE, Heidelberg (Germany); HK, Hong Kong; ML, Mali; MR, Morocco; MX, Monterrey
(Mexico); OK, Oklahoma City (Oklahoma); SA, Cape Town (South Africa); PH, The Philippines; TL, Thailand; TW, Taipei (Taiwan); USA, Los
Angeles (California).
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cancer but is not among the eight most common HPV types in
cervical smears from asymptomatic patients (23). A prelimi-
nary study of the worldwide diversity of this virus based on the
MY09/11 segment of L1 identified seven different variant ge-
nomes (29).
In total, we analyzed a 637-bp sequence from 66 samples,
which led to the identification of 17 HPV-52 variant genomes
relative to the reference HPV-52 genome (Fig. 4). All except
one of our samples were missing the sequence 5-TTATG-3 at
the genomic positions 7387 to 7391 (Fig. 4). In order to clarify
this unexpected finding, Wayne D. Lancaster kindly supplied
us with the original HPV-52 reference isolate. Resequencing of
this isolate confirmed a lack of this sequence, indicating an
error in the establishment of the original HPV-52 sequence
(27). We refer to the corrected sequence, i.e., the omission of
the 5-bp segment, as the HPV-52 reference sequence and have
submitted this correction to GenBank. However, in order to
maintain an unequivocal discussion, the numbers in the fol-
lowing two paragraphs refer to the genomic positions of the
uncorrected reference sequence.
A single sample, BR0258, contained a 3-bp insert at exactly
the same position where the five nucleotides were omitted,
retaining the sequence 5-ATG-3 at this position. In addition
to the 5-ATG-3 insertion, it contained a 4-bp deletion (posi-
tion 7383 to 7386), two deletions of one nucleotide, a 6-bp
insertion (between positions 7701 and 7702 of the original
uncorrected sequence) which was not found in any other vari-
ant, and 10 nucleotide exchanges. As a result, this variant had
the largest distance (14 mutations) from the reference clone of
all HPV-52 variants in this study. MX706 was, with a total of 13
changes relative to the reference clone, the second most di-
verse variant and differed from the reference sequence by a
3-bp deletion (positions 7698 to 7700 of the original reference
genomic count) and 12 nucleotide exchanges. BR0258 and
MX706 differed from one another by 23 mutations, which
constituted the largest distance between any two HPV-52 vari-
ants (3.6% of 637 bp). In Fig. 5, this is topologically reflected
by two deep branches in the UPGMA phylogenetic tree (large
figure) as well as in the neighbor-joining tree (insert). This
figure shows all isolates based on the UPGMA algorithm
(large figure), with a second tree based on neighbor joining,
where each variant is represented by a single isolate (small
insert).
Interestingly, the same 3-bp deletion observed in BR0258
was also present in all twelve samples from Hong Kong, Tai-
wan, and Thailand, as well as in two other Brazilian and two
Mexican samples. Nine of the twelve East Asian samples car-
ried another 2-bp deletion (position 7286 to 7287), which oc-
curred in no other isolate. This large number of geographic-
phylogenetic correlations suggests the case for an Asian-Native
American phylogenetic branch (Fig. 5), similar to the Asian-
American branch in HPV-16 (16) and the Asian branch in
HPV-18. The only exceptions of this correlation were the pres-
ence of a variant with the same characteristics in a sample from
Morocco (MR9411) and the presence of a variant that pre-
dominated in European samples in the only sample from the
Philippines, which may have originated from a recent transfer.
In contrast to this Asian branch, all eight samples from South
Africa were identical or very similar to samples from Europe
or American immigrant countries and did not establish a sep-
arate African branch as in HPV-16 and -18.
Genomic diversity of HPV-58 isolates. The HPV-58 refer-
ence genome was cloned from a squamous cervical carcinoma
(22). HPV-58 is considered the seventh most common high-
risk HPV type in cervical cancer and the sixth most common in
asymptomatic cervical samples (23). Two previous studies
identified seven (29) and eight (7) genomic variants of HPV-58
based on partial L1 sequences.
We analyzed a 461-bp segment of 101 samples, which led to
the identification of 21 variants (including the reference ge-
nome) relative to the reference HPV-58 genome. Surprisingly,
none of the isolates represented the sequence of the reference
genome, while a variant that differed by a single nucleotide
substitution was found in 61 of the 101 samples. Eighteen of
the remaining variants differed only by nucleotide substitu-
tions, while one (ED18136) had a single nucleotide deletion.
FIG. 2. Mutational patterns in HPV-35 variants. The two top rows indicate the genomic position in the HPV-35 reference clone and the
corresponding nucleotides. In the following rows, nucleotide exchanges are shown by letters, deletions relative to the reference clone by a hyphen,
and an insert in some variants by an open square in variants that lack this insert. The positions 7412 and 7413 are listed to indicate the position
of the insert.
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The maximal distance between any two variants was 10 muta-
tions (2.2%).
The most common variant, represented by BR63, occurred
in South African samples (6 of 11), Scottish samples (4 of 7),
and East Asian samples (2 of 7), preventing a clear geographic
association of this variant. However, four samples (represented
by SA013) contained a unique South African variant, and three
samples contained a variant found only in Taiwan (but not in
other Asian countries), showing a limited amount of diversifi-
cation in unique geographic locations. Figure 6 shows a phy-
logenetic tree of all isolates based on the UPGMA algorithm
(large figure) and a second tree based on the neighbor-joining
algorithm, in which each variant is represented by a single
isolate (small insert).
Diversity in the E6 oncogene and a conserved part of the L1
gene. In order to evaluate the potential for functional changes
of HPV proteins, whose genes are linked to LCR variation, we
compared HPV-31, -35, -53, and -58 variants selected from
remote branches of the phylogenetic tree. For these 25 se-
lected variants, we determined the sequences of the complete
E6 gene and about a third of the L1 gene (i.e., that bracketed
by the MY09/11 PCR primers).
FIG. 3. The intratype diversity of HPV-35. The phylogenetic trees represent the relationship between HPV-35 variants based on an 814-bp
segment of the LCR. The large tree is based on the UPGMA, and the small tree is based on the neighbor-joining algorithm. For further details,
see the legend to Fig. 1.
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The sequence data are summarized in Fig. 7 and show the
nucleotide and amino acid sequence changes of six or seven
variants of each of the four HPV types. Within the L1 segment
of 25 variants, we found the prototype amino acid sequence in
19 variants, single amino acid sequence exchanges in 1 HPV-35
variant and 1 HPV-52 variant, and a triple amino acid ex-
change in an HPV-58 variant. These changes were the conse-
quence of zero to seven nucleotide exchanges, amounting to a
maximal divergence of 1.6% from the prototype and maximal
intervariant diversity of 11 nucleotides (2.4%). In the E6 gene,
maximal divergence from the prototype was five nucleotides
(1.1%) and maximal intervariant diversity was eight nucleo-
tides (1.8%). Altogether, the E6 protein of 14 of the 25 vari-
ants was unaltered. There were single amino acid exchanges in
four variants of HPV-35, in two of HPV-52, and in one of
HPV-58, and there were two amino acid exchanges in one
HPV-31 variant and one HPV-52 variant.
DISCUSSION
Our research expands the knowledge about the intratype
genomic diversity of HPVs, which has now been thoroughly
studied for HPV-2, -5, -6, -11, -16, -18, -31, -35, -44, -45, -52,
-53, -56, -58, -66, and -68 (6, 8, 10, 14, 15, 16, 24, 26, 29). An
important outcome of these extensive comparisons is the fact
that there is not an unlimited continuum of diverse genomes of
any HPV type, i.e., divergence never exceeds 2% in L1 and 5%
in the LCR. This cannot be an artifact of the sampling process,
since each of the isolates in this and other studies was typed in
the respective laboratory of origin by amplification with con-
sensus primers and hybridization to type-specific probes, which
would have detected very diverse genomes. The laboratories at
the Ludwig Institute, Sao Paulo, Brazil, and at the University
of California—Irvine also reevaluated all samples and were
able to amplify almost 100% of the samples with type-specific
primers. Therefore, we are confident that no hypothetical
highly diverse variants were lost due to primer design con-
straints.
The limited amount of diversity is astonishing, considering
the fact that HPV types likely originated from progenitor pap-
illomaviruses quite unlike the extant HPVs by a process of
continuous accumulation of mutations. It is therefore not triv-
ial to reason why all the intermediary genomes that led to
present day HPV types are now missing. One possibility likely
involves biologic advantages acquired by genomic change.
Even small improvements (e.g., slightly faster replication or
higher infectivity) may, over extended periods of time, alter the
composition of an HPV population. By positive selection, func-
tionally improved genomes would eventually outnumber par-
ent genomes over time merely by stochastic processes. Another
facet of papillomavirus evolution almost certainly involves ge-
netic drift. Genetic drift can become manifested by founder
effects and bottlenecks, i.e., the limited genomic diversity of an
HPV type in very small populations of infected individuals who
eventually give rise to large populations, for example, at the
very origin of the evolution of Homo sapiens. This hypothesis is
supported by the fact that the chimpanzee papillomaviruses
are more closely related to some HPV types (notably HPV-13)
(30) than are closely related HPV types to one another, e.g.,
HPV-13 to HPV-6 and -11. Such observations support the idea
that even closely related HPVs had already diversified into
separate types in prehuman primates and the small popula-
tions of primates that evolved into new host species, such as
Homo sapiens, may have carried only a fraction of the genomic
FIG. 4. Mutational patterns in HPV-52 variants. The two top rows indicate the genomic position in the published HPV-52 reference sequence
and the corresponding nucleotides. Positions 7387 to 8391 could not be detected by resequencing the original reference clone or in any variants,
leading to the corrected sequence of the HPV-52 reference clone in the third row (refer. cor.). In the following rows, nucleotide exchanges are
shown by letters, deletions relative to the reference clone by a hyphen, and an insert in one variant (between positions 7701 and 7702) by an open
square in variants that lack this insert.
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diversity that existed in the total population of those primates.
Thus, a likely mechanism for the evolution of new HPV types
was the extinction of hosts close to the evolutionary roots of
Homo sapiens. Positive selection and bottlenecks could suffice
to explain the origin of closely related HPV types. Presently,
available data neither support nor exclude the possibility that
in addition, competition between HPV types and selection of
the host against virus mutations contributed to the phyloge-
netic processes.
In the study of HPV-16 and -18 variation, we found a nu-
cleotide divergence of 1 to 5% in the LCR between those
variants that predominate today in Africa, Europe, and East
Asia. Since the emergence of the predominant ethnic groups in
these continents took 10,000 to a few tens of thousands of
years, we interpret our findings to indicate that the speed of
evolution of most HPV types occurred at a rate of roughly 1%
per 10,000 years. This estimate may well be at the high end. For
example, the ubiquitous occurrence of E variants of HPV-16 in
all three continents indicates that these variants may have
existed already while the other variants emerged. Our data may
indicate an even lower speed of genomic change for HPV-31,
-35, -52, and -58, since we found some variants of each type in
FIG. 5. The intratype diversity of HPV-52. The phylogenetic trees represent the relationship between HPV-52 variants based on a 637-bp
segment of the LCR. The large tree is based on the UPGMA, and the small tree is based on the neighbor-joining algorithm. For further details,
see the legend to Fig. 1.
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Africa, Europe, and Asia. These widespread variants may have
existed well before the spread of humans out of Africa, while
clusters that are specific for ethnic groups may have evolved
subsequently in specific locations.
Our data support the notion that HPV sequences encoding
proteins developed a lower diversity than the noncoding LCR.
However, our limited study of the E6 and L1 genes of the most
distant variants of each type, aside from prototype sequences,
indicate a level of 0.7 to 2.1% diversity on the level of protein
sequences. This finding points to the possibility of functional
differences between variants within each type, which is of rel-
evance for epidemiological, etiological, pharmaceutical, and
vaccination research. It should be noted that molecular as well
as epidemiological studies have identified quite significant
FIG. 6. The intratype diversity of HPV-58. The phylogenetic trees represent the relationship between HPV-52 variants based on a 461-bp
segment of the LCR. The large tree is based on the UPGMA, and the small tree is based on the neighbor-joining algorithm. For further details,
see the legend to Fig. 1.
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FIG. 7. Diversity of the E6 genes (four panels on the right side of the figure) and part of the L1 genes (left side of the figure) in distantly related
variants of HPV-31, -35, -52, and -58. Within each panel, the first column lists the variants, whose relative phylogenetic position can be found in
Fig. 1, 3, 5, and 6. The central part of the figure identifies nucleotide exchanges (letters) or maintenance of the sequence of the reference genome
(gray squares). The box on the right side of each panel indicates whether the amino acid sequence of the reference clone has been maintained
(“prototype”) and if not, what kind of amino acid exchanges have occurred.
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functional differences between variants of HPV-16, which
seem to stem from diversity in the LCR as well as in protein-
encoding regions of the genome (13, 17–19, 28, 29, 31, 32–34).
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